Stent Thrombosis After Short-term Discontinuation of Ticagrelor for Coronary Artery Bypass Grafting.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31302083.
- Also identified by DOI 10.1016/j.athoracsur.2019.05.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The optimum antithrombotic strategy before open heart surgery in patients with recently implanted coronary stents has not been clearly established because of lack of clinical evidence. This report describes a case of stent thrombosis in a patient who discontinued a P2Y<sub>12</sub> inhibitor (ticagrelor) for 3 days before coronary artery bypass grafting. The period of withdrawal of antiplatelet drugs before coronary artery bypass grafting should be minimized in patients with recently implanted drug-eluting coronary stents to prevent stent thrombosis.
Medical subject headings
- Coronary Artery Bypass
- Platelet Aggregation Inhibitors
- Postoperative Complications
- Stents
- Thrombosis
- Ticagrelor